Concepedia
Statistics
Publications
53
Citations
4.3K
H-Index
32
Active since
1959
Affiliations
Bristol-Myers Squibb (United States)(Current)
Bristol-Myers Squibb (Germany)
Purdue University West Lafayette
Harvard University
Dana-Farber/Harvard Cancer Center
Robert A. Kramer is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and oncology.
Publications per year
1959–2023
BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
Francis Y. F. Lee, R. M. Borzilleri, Craig R. Fairchild et al. · PubMed · 2001 · 455 citations
Medicine, Oncology, Pharmacology +13
Role of the Glutathione Redox Cycle in Acquired and de Novo Multidrug Resistance
Robert A. Kramer, Jehane Zakher, George Kim · Science · 1988 · 298 citations
Medicine, Oncology, Pharmacology +17
The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin
Stephen Gately, Przemyslaw Twardowski, M. Sharon Stack et al. · Proceedings of the National Academy of Sciences · 1997 · 292 citations · Full text
Medicine, Oncology, Pharmacology +8
BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR
Joan M. Carboni, Mark D. Wittman, Zheng Yang et al. · Molecular Cancer Therapeutics · 2009 · 281 citations · Full text
Medicine, Cancer Biology, Medicinal Chemistry +16
Liquid phase-enabled reaction of Al–Ga and Al–Ga–In–Sn alloys with water
Jeffrey T. Ziebarth, J. M. Woodall, Robert A. Kramer · International Journal of Hydrogen Energy · 2011 · 229 citations
Natural Sciences, Materials Engineering, Materials Science +17
1–5 of 53